212 related articles for article (PubMed ID: 19633770)
1. Diagnostics of cerebral gliomas with radiolabeled amino acids.
Langen KJ; Tatsch K; Grosu AL; Jacobs AH; Weckesser M; Sabri O
Dtsch Arztebl Int; 2008 Jan; 105(4):55-61. PubMed ID: 19633770
[TBL] [Abstract][Full Text] [Related]
2. [Use of amino acid PET in the Diagnostic and Treatment Management of cerebral gliomas].
Galldiks N; Langen KJ
Fortschr Neurol Psychiatr; 2012 Jan; 80(1):17-23. PubMed ID: 22161228
[TBL] [Abstract][Full Text] [Related]
3. [German guidelines for brain tumour imaging by PET and SPECT using labelled amino acids].
Langen KJ; Bartenstein P; Boecker H; Brust P; Coenen HH; Drzezga A; Grünwald F; Krause BJ; Kuwert T; Sabri O; Tatsch K; Weber WA; Schreckenberger M
Nuklearmedizin; 2011; 50(4):167-73. PubMed ID: 21789338
[TBL] [Abstract][Full Text] [Related]
4. Applications of PET imaging of neurological tumors with radiolabeled amino acids.
Galldiks N; Langen KJ
Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):70-82. PubMed ID: 25517079
[TBL] [Abstract][Full Text] [Related]
5. [Improved diagnostics of cerebral gliomas using FET PET].
Langen KJ; Floeth FW; Stoffels G; Hamacher K; Coenen HH; Pauleit D
Z Med Phys; 2007; 17(4):237-41. PubMed ID: 18254545
[TBL] [Abstract][Full Text] [Related]
6. Imaging gliomas with positron emission tomography and single-photon emission computed tomography.
Bénard F; Romsa J; Hustinx R
Semin Nucl Med; 2003 Apr; 33(2):148-62. PubMed ID: 12756647
[TBL] [Abstract][Full Text] [Related]
7. From the clinician's point of view - What is the status quo of positron emission tomography in patients with brain tumors?
Galldiks N; Langen KJ; Pope WB
Neuro Oncol; 2015 Nov; 17(11):1434-44. PubMed ID: 26130743
[TBL] [Abstract][Full Text] [Related]
8. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
[TBL] [Abstract][Full Text] [Related]
9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
10. PET and SPECT for radiation treatment planning.
Götz L; Spehl TS; Weber WA; Grosu AL
Q J Nucl Med Mol Imaging; 2012 Apr; 56(2):163-72. PubMed ID: 22617238
[TBL] [Abstract][Full Text] [Related]
11. PET and SPECT studies in children with hemispheric low-grade gliomas.
Juhász C; Bosnyák E
Childs Nerv Syst; 2016 Oct; 32(10):1823-32. PubMed ID: 27659825
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of positron emission tomographic studies for gliomas.
Miyake K; Ogawa D; Okada M; Hatakeyama T; Tamiya T
Neurol Med Chir (Tokyo); 2016 Jul; 56(7):396-408. PubMed ID: 27250577
[TBL] [Abstract][Full Text] [Related]
13. Assessment of clinical usefulness of 131I alpha-methyl-tyrosine and fused SPECT/MRI imaging for diagnostics of recurrent cerebral gliomas.
Górska-Chrzastek M; Grzelak P; Bieńkiewicz M; Tybor K; Zakrzewska E; Mikołajczak R; Stefańczyk L; Kuśmierek J
Nucl Med Rev Cent East Eur; 2004; 7(2):135-41. PubMed ID: 15968600
[TBL] [Abstract][Full Text] [Related]
14. Recurrent cerebral gliomas in MRI and Iodine-123[corrected]-alpha-methyl-tyrosine SPECT: the use of digitally fused images.
Grzelak P; Górska-Chrzastek M; Gajewicz W; Kuśmierek J; Tybor K; Stefańczyk L
Nucl Med Rev Cent East Eur; 2005; 8(2):94-9. PubMed ID: 16437393
[TBL] [Abstract][Full Text] [Related]
15. Role of amino-acid PET in high-grade gliomas: limitations and perspectives.
Verger A; Arbizu J; Law I
Q J Nucl Med Mol Imaging; 2018 Sep; 62(3):254-266. PubMed ID: 29696948
[TBL] [Abstract][Full Text] [Related]
16. Comparison between contrast-enhanced magnetic resonance imaging and technetium 99m glucohepatonic acid single photon emission computed tomography with histopathologic correlation in gliomas.
Kumar RA; Khandelwal N; Sodhi KS; Pathak A; Mittal BR; Radotra BD; Suri S
J Comput Assist Tomogr; 2006; 30(5):723-33. PubMed ID: 16954918
[TBL] [Abstract][Full Text] [Related]
17. Imaging of amino acid transport in brain tumours: Positron emission tomography with O-(2-[
Langen KJ; Stoffels G; Filss C; Heinzel A; Stegmayr C; Lohmann P; Willuweit A; Neumaier B; Mottaghy FM; Galldiks N
Methods; 2017 Nov; 130():124-134. PubMed ID: 28552264
[TBL] [Abstract][Full Text] [Related]
18. Advantages and limitations of amino acid PET for tracking therapy response in glioma patients.
Langen KJ; Heinzel A; Lohmann P; Mottaghy FM; Galldiks N
Expert Rev Neurother; 2020 Feb; 20(2):137-146. PubMed ID: 31829748
[No Abstract] [Full Text] [Related]
19. Positron emission tomography for radiation treatment planning.
Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
